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(7). The remaining 1 is from Japan and 
assigned to ST28 (8). Unlike in previ-
ous reports, 80% of the human clinical 
isolates (16 isolates) characterized in 
this study were assigned to the ST27 
complex. Although previous studies 
suggested that members of the ST27 
complex may have lower potential to 
cause invasive diseases in swine (7), 
all the isolates were isolated from 
blood or cerebrospinal ﬂ   uid of the 
patients, suggesting a high degree of 
invasiveness (Table). Because it is 
unknown whether the ST27 complex 
is also dominant among isolates from 
diseased pigs in Thailand, future sur-
veillance  will be necessary to know 
the situation in pigs. However, our 
data indicate that the ST27 complex 
is another clonal group that should be 
assessed for its importance for human 
infection. Because mrp,  epf, and sly 
are not appropriate as virulence mark-
ers for the ST27 complex members, 
development of novel virulence mark-
ers will be needed for efﬁ  cient dis-
crimination of S. suis strains virulent 
for humans. 
This study made use of the Strepto-
coccus suis Multilocus Sequence Typing 
website (http://ssuis.mlst.net); this site is 
hosted at Imperial College and develop-
ment is funded by the Wellcome Trust. The 
study was supported by a grant-in-aid from 
the Zoonoses Control Project of the Min-
istry of Agriculture, Forestry and Fisher-
ies of Japan and the Endowment Fund for 
Medical Research, Faculty of Medicine, 
Chiang Mai University.
Daisuke Takamatsu,* 
Korawan Wongsawan,† 
Makoto Osaki,* 
Hiroto Nishino,‡ Tomono Ishiji,§ 
Prasit Tharavichitkul,† 
Banyong Khantawa,† 
Achara Fongcom,¶ 
Shinji Takai,# 
and Tsutomu Sekizaki*, **
*National Institute of Animal Health, Tsuku-
ba, Ibaraki, Japan; †Chiang Mai University, 
Chiang Mai, Thailand; ‡Northern District 
Livestock Health and Hygiene Ofﬁ  ce, Mito, 
Ibaraki, Japan; §Seibu Livestock Hygiene 
Service Center, Tonami, Toyama, Japan; 
¶Lamphun Provincial Hospital, Lamphun, 
Thailand; #Kitasato University, Towada, 
Aomori, Japan; and **Gifu University, Gifu, 
Gifu, Japan
References
  1.   Staats JJ, Feder I, Okwumabua O, Chen-
gappa MM. Streptococcus suis: past and 
present. Vet Res Commun. 1997;21:
381–407.
    2.   Vecht U, Wisselink HJ, van Dijk JE, 
Smith HE. Virulence of Streptococcus 
suis type 2 strains in newborn germfree 
pigs depends on phenotype. Infect Immun. 
1992;60:550–6.
  3.   Jacobs AAC, Loeffen PLW, van den Berg 
AJG, Storm PK. Identiﬁ  cation, puriﬁ  ca-
tion, and characterization of a thiol-acti-
vated hemolysin (suilysin) of Streptococ-
cus suis. Infect Immun. 1994;62:1742–8.
    4.    Smith HE, Damman M, van der Velde 
J, Wagenaar F, Wisselink HJ, Stock-
hofe-Zurwieden N, et al. Identiﬁ  cation 
and characterization of the cps locus of 
Streptococcus suis serotype 2: the capsule 
protects against phagocytosis and is an 
important virulence factor. Infect Immun. 
1999;67:1750–6.
  5.   Vecht U, Wisselink HJ, Jellema ML, Smith 
HE. Identiﬁ  cation of two proteins associ-
ated with virulence of Streptococcus suis 
type 2. Infect Immun. 1991;59:3156–62.
  6.   Gottschalk  M,  Lebrun  A,  Wisselink  H, 
Dubreuil JD, Smith H, Vecht U. Produc-
tion of virulence-related proteins by Cana-
dian strains of Streptococcus suis capsular 
type 2. Can J Vet Res. 1998;62:75–9.
  7.   King SJ, Leigh JA, Heath PJ, Luque I, Tar-
radas C, Dowson CG, et al. Development 
of a multilocus sequence typing scheme 
for the pig pathogen Streptococcus suis: 
identiﬁ  cation of virulent clones and po-
tential capsular serotype exchange. J Clin 
Microbiol. 2002;40:3671–80.
  8.   Chang B, Wada A, Ikebe T, Ohnishi M, 
Mita K, Endo M, et al. Characteritics of 
Streptococcus suis isolated from patients 
in Japan. Jpn J Infect Dis. 2006;59:397–9.
  9.   Ye C, Zhu X, Jing H, Du H, Segura M, 
Zheng H, et al. Streptococcus suis se-
quence type 7 outbreak, Sichuan, China. 
Emerg Infect Dis. 2006;12:1203–8.
10.    Silva LMG, Baums CG, Rehm T, Wis-
selink HJ, Goethe R, Valentin-Weigand 
P. Virulence-associated gene proﬁ  ling of 
Streptococcus suis isolates by PCR. Vet 
Microbiol. 2006;115:117–27.
Address for correspondence: Tsutomu Sekizaki, 
National Institute of Animal Health, 3-1-5 
Kannondai, Tsukuba, Ibaraki 305-0856, Japan; 
email: sekizaki@affrc.go.jp
Streptococcus suis 
Meningitis, United 
States
To the Editor:  Streptococcus 
suis,  commensal and opportunistic 
pathogens of swine, and prevalent 
zoonotic agents worldwide, are α-he-
molytic gram-positive cocci with 35 
different serotypes (1). In humans, S. 
suis infection has been associated with 
bacterial meningitis, septic shock, ar-
thritis, pneumonia, endocarditis, en-
dophthalmitis, and spontaneous bacte-
rial peritonitis (2,3). Most at risk are 
those who handle or eat undercooked 
pork, e.g., farm workers, butchers, 
and slaughterhouse workers (4). Most 
cases have been reported in Europe or 
Southeast Asia (2,3). Meningitis, ﬁ  rst 
recognized in 1968 in Denmark (1), is 
the most common clinical manifesta-
tion of human infection with S. suis. A 
case of S. suis meningitis in a pig farm-
er was reported in the United States 
(5). Here, we describe another case in 
a 60-year-old man from San Francisco 
who had consumed raw pork while 
traveling in the Philippines.
In June 2003, this man became 
ill with fever, diaphoresis, headache, 
nausea, and anorexia. He had just re-
turned from a 7-month vacation in the 
Philippines. Three days after symp-
toms onset, his physician prescribed 
doxycycline. Symptoms continued 
and he was admitted to a local hospi-
tal 5 days later with a fever of 38.9°C, 
nuchal rigidity, headache, and general 
malaise. 
The patient described no recent 
contact with sick persons; past medical 
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cal examination, he was somnolent but 
fully oriented, with no focal ﬁ  ndings 
on neurologic examination and only 
slight nuchal rigidity. He had a leuko-
cyte count of 21,000/mm3, including 
16,400/mm3 neutrophils. Cerebrospinal 
ﬂ  uid (CSF) showed leukocyte count of 
487/μL with 80% polymorphonuclear 
cells and 18% lymphocytes, and glu-
cose and protein levels <20 mg/dL and 
<167 mg/dL, respectively. Gram stain 
of CSF showed gram-positive cocci 
in pairs. Empiric therapy (ceftriaxone, 
vancomycin, and ampicillin) for bacte-
rial meningitis was begun. Computed 
tomographic scan of the head showed 
only sinusitis; ﬁ  ndings of chest radio-
graph and transesophageal echocardio-
gram were negative.
On hospital day 2, blood cultures 
grew gram-positive cocci in pairs and 
chains  (Figure).  The organism was 
catalase-negative, bile esculin-nega-
tive, and pyrrolidonyl aminopeptidase-
negative, consistent with Streptococ-
cus spp. A latex agglutination test did 
not detect Streptococcus pneumoniae 
antigen. Antimicrobial susceptibility 
testing showed that the isolate was 
sensitive to penicillin (MIC = 0.03), 
ceftriaxone, and vancomycin but resis-
tant to tetracycline and clindamycin. 
Antimicrobial therapy was changed to 
penicillin G, 24 million units intrave-
nously per day. 
On hospital day 5, the patient 
complained of hearing loss in his left 
ear. Results of nasopharyngeal endos-
copy were negative. By hospital day 7, 
the organism was identiﬁ  ed by the API 
20 Strep System (bioMerieux, Marcy 
l’Etoile, France) as S. suis serotype 2. 
The patient subsequently stated that he 
was a butcher with a culinary prefer-
ence for partially cooked pork, which 
he had eaten in the Philippines until 
the week prior to onset of symptoms. 
On hospital day 9, a formal audiology 
evaluation showed severe bilateral 
sensorineural high-frequency hearing 
loss (–70 dB). The patient completed 
a 10-day course of parenteral antimi-
crobial drugs and was discharged on 
continued oral therapy with close fol-
lowup. Two months after discharge, 
the patient reported much improved 
hearing without other sequelae.
Most S. suis infections occur in 
older men and patients who report con-
tact with pigs or eating undercooked 
pork products. Invasion of the blood-
stream can occur directly through skin 
abrasions or the oral or respiratory 
route (6). Once bloodborne, S. suis 
can cause toxic shock syndrome and 
sepsis (7). The mechanism by which 
the organism traverses the blood-
brain barrier to cause meningitis is not 
known, although bacterial toxins and 
host inﬂ  ammatory mediators may play 
a role (8). 
Hearing loss from S. suis men-
ingitis, although not speciﬁ  c for the 
organism, occurs frequently in half to 
two thirds of patients and can be irre-
versible (3,7,9). Administering dexa-
methasone may ameliorate hearing 
loss in some cases (10). Penicillin G 
is the preferred treatment for S. suis 
infection, although penicillin resis-
tance has emerged in S. suis because 
of  the farm practice of supplementing 
feeds with antimicrobial drugs. As an 
alternative therapy, vancomycin may 
be used (6). Thus, empiric therapy for 
adult bacterial meningitis (ceftriax-
one and vancomycin with or without 
ampicillin) would likely be sufﬁ  cient 
to treat S. suis meningitis. Although 
the death rate from this disease can be 
high, varying from 7% in one study 
(3) to 30% in another (6), infection 
can be prevented by treating abra-
sions promptly, wearing gloves when 
handling pork, adhering to proper 
hand washing techniques, and sufﬁ  -
ciently cooking pork products (3).
S. suis infection may go unrec-
ognized since many laboratories do 
not routinely speciate α-hemolytic 
streptococci. However, in the United 
States, specialized tests such as the 
API 20 Strep System (API System; La 
Balme Les Grottes, Montalieu-Ver-
cieu, France) or reference laboratories 
are readily available for diagnosis of 
all unidentiﬁ  ed streptococci. In severe 
cases where infection is suspected, 
physicians may request that laborato-
ries conduct deﬁ  nitive tests to identify 
the organism. In countries that lack 
these resources and where under-
Figure. Gram-positive cocci in pairs in a 60-year-old man with meningitis. Magniﬁ  cation 
x1,000.
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agnosis of S. suis infection is likely. 
Greater understanding of this organ-
ism and its disease spectrum would 
promote earlier diagnosis and preven-
tion of sequelae. 
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Parvoviruses in 
Blood Donors and 
Transplant 
Patients, Italy
To the Editor: Parvoviruses 
(PARV) 4 and 5 are 2 genotypes of 
a novel human parvovirus, with 92% 
nucleotide identity, identiﬁ   ed in the 
plasma sample of a patient screened 
for acute HIV infection and in samples 
of manufactured plasma pools (1,2). 
Recently, PARV4 and PARV5 were 
identiﬁ  ed in blood samples from 3 of 
26 cadavers from the United Kingdom, 
all of whom were positive for hepatitis 
C virus RNA and had a history of in-
travenous drug use (3). PARV4/5 were 
also found in bone marrow (BM) and 
lymphoid tissues from 17 of 24 HIV-
positive cadavers from Scotland (4) 
and in BM aspirates from 16 of 35 Ital-
ian patients with AIDS (5). Little or no 
information is available about the epi-
demiology and clinical correlates of 
infection with these novel viruses. To 
provide insights into their pathogenic 
potential in vivo, we assessed the fre-
quency of PARV4/5 viremia in healthy 
patients, transplant patients, and those 
with suspected viral disease. 
We performed a retrospective 
molecular study for the presence of 
PARV4/5 sequences in 4 groups of 
417 Italian HIV-negative persons. 
Group 1 consisted of 100 blood donors 
recruited from the Transfusion Centre 
of Modena (northern Italy); group 2, 
84 patients with hematologic diseases 
showing clinical signs of viral etiol-
ogy but negative results for the most 
common viruses (herpesviruses, ade-
novirus, hepatitis virus, and coxsackie 
virus). For both of these groups, DNA 
was extracted for analysis from se-
rum specimens and peripheral blood 
mononuclear cells (PBMCs). Groups 
3 and 4 comprised recipients of kid-
ney and allogeneic BM/peripheral 
blood stem cell (PBSC) transplants, 
for which DNA was extracted from 
serum specimens collected at 6 and 
12 months, respectively, after trans-
plantation. The nested PCR method 
was used to amplify a shared sequence 
of PARV4 and its variant PARV5 
and was speciﬁ  c for the open read-
ing frame 1. First step PCR was per-
formed as previously described (2) 
with a sensitivity of 1–10 copies, on 
1 μg PBMC DNA and on one ﬁ  fth of 
DNA extracted from 0.25 mL of serum. 
Primers for second round PCR were 
PV4NS1Fn2 (5′-GTTGATGGYCCT-
GTGGTTAG-3′) and PV4NS1Rn2 
(5′-CCTTTCATATTCAGTTCCT-
GTTCAC-3′). All positive results were 
conﬁ  rmed by direct sequencing.
We found 3 positive case-patients, 
including 2 renal transplant recipients 
and 1 patient with a suspected viral 
disease; none of the blood donors test-
ed positive on single-round PCR. On 
nested PCR, 1 blood donor had posi-
tive results; the positivity rate did not 
increase in the other groups (Table). In 
the ﬁ  rst 2 groups, PARV4/5 sequences 
were detected only in the serum sam-
ples, not in the PBMCs collected at the 
same time. These sequences suggest 
that PBMCs are not a major site of 
viral replication. Similar to B19 infec-
tion, which is rarely reactivated in the 
setting of BM/PBSC transplantation 
(6,7), none of the BM/PBSC trans-
plant patients were PARV4/5 positive. 
The detection of PARV4/5 sequences 
in the serum collected at 12 months 
after transplantation was not associ-
ated with the occurrence of any symp-
toms in the 2 renal recipients. Of note, 
the available serum samples collected 
from both recipients before transplan-
tation, and at 6 and 24 months after 
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